Exploring Mitochondrial Myopathy
Welcome to our comprehensive guide on Mitochondrial Myopathy.
- This MDA webinar, held on October 15th, 2025, explains current information on
- In depth interview on disgnosis and evaluation of
- Mitochondrial myopathies
- Dr. Mark Tarnopolsky explains the difference between primary and secondary
- Rennie McCarthy, Chief Executive Officer at Stealth Biotherapeutics, provides an overview of
In-Depth Information on Mitochondrial Myopathy
Primary This week The Means Report turns its focus to Alex Dorenbaum, MD, Chief Medical Officer of Reneo Pharmaceuticals, gives an overview of primary Professor Doug Turnbull discussing his role in groundbreaking advancements for
Michelangelo Mancuso, MD, PhD, University Hospital of Pisa, Pisa, Italy, gives guidance for diagnosing primary
In summary, understanding Mitochondrial Myopathy gives us a better perspective.
